NEW YORK (GenomeWeb) – Bio-Rad Laboratories reported after the close of the market Thursday that its third quarter revenues increased 2 percent year over year driven by sales for its life science segment.

The Hercules, California-based life science research tools and diagnostics firm reported total revenues of $545.1 million for the three months ended Sept. 30, up from $534.1 million for the third quarter of 2017. It beat the consensus Wall Street estimate for revenues of $538.7 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study finds that a placental protein linked with preeclampsia can be targeted by RNA silencing, according to the New Scientist.

A settlement is expected in a Duke University lawsuit hinging on using falsified data to win grants, Retraction Watch and Science report.

In PNAS this week: approach for analyzing the expression of endogenous retroviruses, circular RNAs that influence host-virus interactions, and more.

A phylogenetic analysis finds that the rare hemimastigotes form their own supra-kingdom, CBC reports.